Literature DB >> 3092415

Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa.

F W Van der Waals, K L Pomeroy, J Goudsmit, D M Asher, D C Gajdusek.   

Abstract

Serum samples from 119 healthy individuals and 106 epilepsy patients inhabiting Grand Bassa County, Liberia, were tested for antibodies to hemorrhagic fever viruses (HFV) by indirect immunofluorescence. E6 Vero cells infected with Lassa fever virus (LAS), Rift Valley Fever virus (RVF), Congo Hemorrhagic Fever virus (CON), Marburg virus (MBG) and the Ebola (EBO) virus strains Mayinga (May) and Boniface (Bon) were used as antigen. To obtain reproducible and specific test results sera had to be absorbed extensively with uninfected E6 Vero cells, tested for reactivity to both virus infected and uninfected E6 Vero cells and read "blindly" by two independent observers. Antibodies to EBO were shown to be highly prevalent (13.4%) in the population of this rainforest area, while prevalences of antibodies to LAS (1.3%), RVF (0.4%) and MBG (1.3%) were much lower. No correlation between past HFV infection and post-encephalitic epilepsy or other reported febrile illnesses could be established.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092415

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  16 in total

1.  Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation.

Authors:  D G Bausch; P E Rollin; A H Demby; M Coulibaly; J Kanu; A S Conteh; K D Wagoner; L K McMullan; M D Bowen; C J Peters; T G Ksiazek
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide?

Authors:  S Becker; H Feldmann; C Will; W Slenczka
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

3.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

4.  Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo.

Authors:  Sabue Mulangu; Vivian H Alfonso; Nicole A Hoff; Reena H Doshi; Prime Mulembakani; Neville K Kisalu; Emile Okitolonda-Wemakoy; Benoit Ilunga Kebela; Hadar Marcus; Joseph Shiloach; Je-Nie Phue; Linda L Wright; Jean-Jacques Muyembe-Tamfum; Nancy J Sullivan; Anne W Rimoin
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

5.  A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection.

Authors:  Nell Bond; John S Schieffelin; Lina M Moses; Andrew J Bennett; Daniel G Bausch
Journal:  Am J Trop Med Hyg       Date:  2013-02       Impact factor: 2.345

6.  Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.

Authors:  Daniel G Bausch; Matthias Borchert; Thomas Grein; Cathy Roth; Robert Swanepoel; Modeste L Libande; Antoine Talarmin; Eric Bertherat; Jean-Jacques Muyembe-Tamfum; Ben Tugume; Robert Colebunders; Kader M Kondé; Patricia Pirad; Loku L Olinda; Guénaël R Rodier; Patricia Campbell; Oyewale Tomori; Thomas G Ksiazek; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

7.  Ebola virus infection: what should be known?

Authors:  Viroj Wiwanitkit
Journal:  N Am J Med Sci       Date:  2014-11

8.  The sensitivity and specificity of Lassa virus IgM by ELISA as screening tool at early phase of Lassa fever infection.

Authors:  Titus S Ibekwe; Maxwell M Nwegbu; Daniel Asogun; Donatus I Adomeh; Peter O Okokhere
Journal:  Niger Med J       Date:  2012-10

9.  Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus.

Authors:  Andreas Lucht; Roland Grunow; Christian Otterbein; Peggy Möller; Heinz Feldmann; Stephan Becker
Journal:  Med Microbiol Immunol       Date:  2003-10-31       Impact factor: 4.148

10.  Mapping transmission risk of Lassa fever in West Africa: the importance of quality control, sampling bias, and error weighting.

Authors:  A Townsend Peterson; Lina M Moses; Daniel G Bausch
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.